We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TLIS market cap is 2.92M. The company's latest EPS is USD -34.0171 and P/E is -0.13.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.98M | 10.94M | 8.19M | 4.81M | 2.13M |
| Operating Income | -26.7M | -91.18M | -191.82M | -111.55M | -64.05M |
| Net Income | -27.47M | -91.13M | -192.04M | -113.01M | -62.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.73M | 198.41M | 265.83M | 169.29M | 94.67M |
| Total Liabilities | 4.12M | 16.03M | 31.85M | 42.55M | 25.56M |
| Total Equity | -21.14M | -108.57M | 233.98M | 126.74M | 69.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.33M | -87.02M | -171.38M | -100.14M | -53.24M |
| Investing | -578k | -8.2M | -2.87M | -1.62M | -486k |
| Financing | 39.61M | 246.75M | 234.43M | 406k | 33k |
| Market Cap | 2.92M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 3.74 |
| Price to Cash Ratio | 0.1 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 1.82M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5.17k |
| 52 Week Change | -60.00% |
| 52 Week High | 4.01 |
| 52 Week Low | 1.37 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Talis Biomedical Corporation (CE) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://talisbio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
